| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.57 | 0.0006 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |